For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The closing price of Acadia Pharmaceuticals Inc (NASDAQ: ACAD) was $21.71 for the day, down -0.14% from the previous closing price of $21.74. In other words, the price has decreased by -$0.14 from its previous closing price. On the day, 1.11 million shares were traded.
Ratios:
Our analysis of ACAD’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.33 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.48. For the most recent quarter (mrq), Quick Ratio is recorded 2.80 and its Current Ratio is at 2.88. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On February 11, 2025, Deutsche Bank started tracking the stock assigning a Hold rating and target price of $22.
Guggenheim Downgraded its Buy to Neutral on January 03, 2025, whereas the target price for the stock was revised from $23 to $20.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 04 ’25 when Brege Laura sold 14,446 shares for $21.78 per share. The transaction valued at 314,634 led to the insider holds 15,095 shares of the business.
LAURA BREGE bought 14,446 shares of ACAD for $314,638 on Jun 04 ’25. On May 16 ’25, another insider, Kihara James, who serves as the PRINCIPAL ACCOUNTING OFFICER of the company, sold 4,000 shares for $22.50 each. As a result, the insider received 90,000 and left with 20,395 shares of the company.
Valuation Measures:
As of this moment, Acadia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.81, and their Forward P/E ratio for the next fiscal year is 25.41. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.36. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.65 while its Price-to-Book (P/B) ratio in mrq is 4.74.
Stock Price History:
Over the past 52 weeks, ACAD has reached a high of $25.23, while it has fallen to a 52-week low of $13.40. The 50-Day Moving Average of the stock is 21.20%, while the 200-Day Moving Average is calculated to be 26.35%.
Shares Statistics:
A total of 167.12M shares are outstanding, with a floating share count of 166.02M. Insiders hold about 0.80% of the company’s shares, while institutions hold 103.73% stake in the company.
